Melissa Kotterman
Investitore di Private Equity presso Berkeley Frontier Fund
Profilo
Melissa Kotterman is the founder of 4D Molecular Therapeutics, Inc. which was founded in 2013.
She held the title of Vice President-Discovery & Engineering from 2013 to 2021.
Dr. Kotterman is also the founder of Ignite Immunotherapy, Inc. Currently, she is a Venture Partner at Berkeley Frontier Fund.
Dr. Kotterman received an undergraduate degree from Carnegie Mellon University and a doctorate degree from the University of California, Berkeley in 2013.
Posizioni attive di Melissa Kotterman
Società | Posizione | Inizio |
---|---|---|
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Investitore di Private Equity | - |
Precedenti posizioni note di Melissa Kotterman
Società | Posizione | Fine |
---|---|---|
4D MOLECULAR THERAPEUTICS, INC. | Fondatore | 01/11/2021 |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Fondatore | - |
Formazione di Melissa Kotterman
Carnegie Mellon University | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Health Technology |
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Finance |
- Borsa valori
- Insiders
- Melissa Kotterman